Background illustration for clinical trials search

Paid Clinical Trials Murfreesboro

Discover 1,249 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

for
In-Stent Restenosis, Cardiovascular Diseases,
Location: Nashville TN, Birmingham AL, Tupelo MS, Decatur GA,
Sponsor: Concept Medical Inc.

Sex: All

Age: 18 - 70+

Code: NCT05908331

Recruiting

A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

for
Polycythemia Vera (PV), Myelofibrosis (MF),
Location: Nashville TN, Grand Rapids MI, Tampa FL, Houston TX,
Sponsor: Prelude Therapeutics

Sex: All

Age: 18+

Code: NCT07469891

Phase1, Recruiting

The ArtixASCEND Study

for
Acute Lower Limb Arterial Occlusion
Location: Nashville TN, Asheville NC, Cincinnati OH,
Sponsor: Inari Medical

Sex: All

Age: 18+

Code: NCT07135895

Recruiting

An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers

for
Advanced Malignancies, Advanced Cancer
Location: Nashville TN, Atlanta GA, Toronto, Coral Springs FL,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07426757

Phase1, Recruiting

ELEVATE High-Risk PCI Pivotal Study

for
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
Location: Nashville TN, Marietta GA, Atlanta GA, Edgewood KY,
Sponsor: Magenta Medical Ltd.

Sex: All

Age: 18 - 70+

Code: NCT07001332

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

HPC Offered for PRESERVE Expansion

for
Bone Marrow Transplant (BMT)
Location: Nashville TN, Birmingham AL, Columbus OH, Detroit MI
Sponsor: Ossium Health, Inc.

Sex: All

Age: 12 - 70+

Code: NCT07145411

Recruiting

A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)

for
Obstructive Hypertrophic Cardiomyopathy
Location: Nashville TN, Tupelo MS, Greenville SC, Cincinnati OH,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT05489705

Recruiting

Delirium Reduction With Ramelteon

for
Delirium
Location: Nashville TN
Sponsor: Centennial Medical Center

Sex: All

Age: 18+

Code: NCT05069428

Recruiting

Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)

for
Tricuspid Regurgitation, Tricuspid Regurgitation Functional
Location: Nashville TN, Cincinnati OH, Detroit MI, Rochester MN,
Sponsor: Innoventric LTD

Sex: All

Age: 18 - 70+

Code: NCT06212193

Recruiting

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

for
Non Small Cell Lung Cancer, Lung Cancer, Breast Cancer,
Location: Nashville TN, Louisville KY, Greenville SC, Chicago IL,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT05983432

Phase1, Recruiting

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

for
Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia,
Location: Nashville TN, Birmingham AL, Cincinnati OH, Houston TX,
Sponsor: Vincerx Pharma, Inc.

Sex: All

Age: 18+

Code: NCT06034275

Phase1, Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Nashville TN, Louisville KY, Atlanta GA, Augusta GA,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase1, Recruiting

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

for
Locally Advanced Solid Tumor
Location: Nashville TN, Urbana IL, Chicago IL, Zion IL,
Sponsor: Tango Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT05732831

Phase1, Phase2, Recruiting

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Nashville TN, Atlanta GA, St Louis MO, Columbus OH,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05384626

Phase1, Phase2, Recruiting

Multi-Institutional Registry for Prostate Cancer Radiosurgery

for
Prostate Cancer Early Risk Treated by Radiosurgery,
Location: Nashville TN, Birmingham AL, Marietta GA, Lexington KY,
Sponsor: RPCR, Inc.

Sex: Male

Age: 18 - 70+

Code: NCT01226004

Recruiting

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

for
Neoplasms
Location: Nashville TN, Atlanta GA, Charlotte NC, Ann Arbor MI,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06150157

Phase1, Recruiting

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

for
Myeloproliferative Neoplasms
Location: Nashville TN, Atlanta GA, Columbus OH
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT07441694

Phase1, Recruiting

A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

for
Hematologic Neoplasms
Location: Nashville TN, Indianapolis IN, Grand Rapids MI,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07572006

Phase1, Recruiting

A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)

for
T-cell Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
Location: Nashville TN, Atlanta GA, Cincinnati OH, St Louis MO,
Sponsor: Allotera Therapeutics

Sex: All

Age: 0+

Code: NCT06514794

Phase2, Recruiting

Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1

for
Relapsed/Refractory Acute Myeloid Leukemia
Location: Nashville TN, Cincinnati OH, Columbus OH, Chicago IL,
Sponsor: SystImmune Inc.

Sex: All

Age: 18+

Code: NCT06714591

Phase1, Recruiting